Wednesday, August 24, 2016

BRIEF-Evgen Pharma granted orphan drug designation for stabilised sulforaphane

* FDA granted company orphan drug designation for use of

stabilised sulforaphane for treatment of subarachnoid

haemorrhage

Source text for Eikon:

Further company coverage:

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)